Molecular Biology Center, Universidad Centroamericana, Managua, Nicaragua
Department of Epidemiology and Biostatistics, The University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, Arizona, USA.
BMJ Open. 2021 Sep 21;11(9):e051836. doi: 10.1136/bmjopen-2021-051836.
This study aimed to capture key epidemiological data on SARS-CoV-2 infection in Nicaraguan children (≤18 years) seeking medical care, between 6 October and 16 November 2020.
In this cross-sectional study, 418 children were recruited: 319 with symptoms characteristic of COVID-19 and 99 with no symptoms of illness. Children were tested for SARS-CoV-2 RNA using loop-mediated isothermal amplification. A questionnaire was employed to identify symptoms, risk factors, comorbidities and COVID-19 prevention measures.
Research was carried out in four hospitals and two clinics in Managua, Nicaragua, where schools and businesses remained open throughout the COVID-19 pandemic.
Children were enrolled into a possible COVID-19 group if presenting with clinical symptoms. A comparison group included children lacking any COVID-19 symptoms attending routine check-ups or seeking care for issues unrelated to COVID-19.
A high prevalence (43%) of SARS-CoV-2 infection was found, which was relatively equivalent in symptomatic and non-symptomatic children. Age distribution was similar between symptomatic and non-symptomatic children testing positive for SARS-CoV-2. Symptomatic children who tested positive for SARS-CoV-2 were 2.7 times more likely to have diarrhoea (26.7% in positive vs 12.0% in negative; OR=2.7 (95% CI 1.5 to 4.8), p=0.001) and were 2.0 times more likely to have myalgia (17.8% in positive vs 9.8% in negative; OR=2.0 (95% CI 1.0 to 3.8), p=0.04). Children with COVID-19 symptoms, who tested positive for SARS-CoV-2, were more likely to be under age 5 years and to have a pre-existing comorbid condition than children who tested positive but did not have symptoms.
This is the first paediatric study to provide laboratory-confirmed data on SARS-CoV-2 infection in Nicaragua, crucial for paediatric health services planning and a successful COVID-19 response. The high prevalence of the virus suggests widespread and sustained community transmission, underscoring the urgent need for robust data on the true extent of SARS-CoV-2 infection throughout Nicaragua.
本研究旨在获取尼加拉瓜儿童(≤18 岁)因医疗原因感染 SARS-CoV-2 的关键流行病学数据,时间为 2020 年 10 月 6 日至 11 月 16 日。
本横断面研究共纳入 418 例儿童:319 例有 COVID-19 症状,99 例无症状。使用环介导等温扩增法检测 SARS-CoV-2 RNA。采用问卷识别症状、危险因素、合并症和 COVID-19 预防措施。
在尼加拉瓜马那瓜的 4 家医院和 2 家诊所进行研究,这些学校和企业在整个 COVID-19 大流行期间保持开放。
如果出现临床症状,则将儿童纳入可能的 COVID-19 组。对照组包括无症状儿童,他们在常规体检时或因 COVID-19 以外的问题就诊。
发现 SARS-CoV-2 感染率较高(43%),在有症状和无症状儿童中相对相等。阳性 SARS-CoV-2 检测的症状和无症状儿童的年龄分布相似。阳性 SARS-CoV-2 检测的有症状儿童腹泻的可能性是阴性儿童的 2.7 倍(阳性 26.7% vs 阴性 12.0%;OR=2.7(95%CI 1.5 至 4.8),p=0.001),肌痛的可能性是阴性儿童的 2.0 倍(阳性 17.8% vs 阴性 9.8%;OR=2.0(95%CI 1.0 至 3.8),p=0.04)。阳性 SARS-CoV-2 检测且有 COVID-19 症状的儿童年龄小于 5 岁和有合并症的可能性大于阳性但无症状的儿童。
这是尼加拉瓜首例提供 SARS-CoV-2 感染实验室确诊数据的儿科研究,对儿科卫生服务规划和 COVID-19 应对至关重要。病毒的高流行率表明社区传播广泛且持续,突显了急需尼加拉瓜全面真实的 SARS-CoV-2 感染数据。